Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional pe... حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional... حسب Naoya Itoh (6029276)

الموضوعات:

Average purchase costs of 3GCs and all oral antimicrobials per 100 patient-days from Phases 1–4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).... حسب Naoya Itoh (6029276)

الموضوعات:

S1 Dataset - حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phas... حسب Naoya Itoh (6029276)

الموضوعات:

Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). حسب Naoya Itoh (6029276)

الموضوعات:

Pop-up for oral 3GC prescription. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Increased and decreased proteins. حسب Diego Iacono (10785756)

GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). حسب Sangeetha Muthamilselvan (8966006)

"…<p>GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value).</p>…"

Spatial heterogeneity in the impact of digital financial inclusion on the carbon reduction gap in agricultural regions. حسب Lingzhi Tan (19146572)

الموضوعات:

Occurrence of species that increased and decreased across surveys. حسب Paul H. Zedler (2905520)

Increasing gaps and decreasing returns attenuate spending effects. حسب William Minozzi (8564712)

Subgroup analysis of antenatal care services reduction during the COVID-19 pandemic in Ethiopia, 2021. حسب Birye Dessalegn Mekonnen (9514106)

الموضوعات: